-
公开(公告)号:US20200331887A1
公开(公告)日:2020-10-22
申请号:US16914142
申请日:2020-06-26
发明人: Pan LI , Qiaodong WEN , Ji WANG , Quan GAN , Yang LU , Donghui YANG
IPC分类号: C07D401/12 , C07D215/14 , C07D409/12 , C07D401/08 , C07D405/08
摘要: The present invention relates to a compound represented by formula I, a pharmaceutical composition containing the compound of formula I, a method for inhibiting indoleamine 2,3-dioxygenase, and its use in medicine.
-
公开(公告)号:US20240189320A1
公开(公告)日:2024-06-13
申请号:US17270480
申请日:2019-08-22
发明人: Yufeng CHEN , Kaixuan CHEN , Pan LI , Canfeng LIU , Ji WANG , Qingchong QIU , Yang LU
IPC分类号: A61K31/5386 , A61K31/437 , A61K31/4985 , A61K31/5383 , A61K31/551 , A61K31/553 , A61P35/00 , C07D471/06 , C07D487/06 , C07D498/06 , C07D498/22 , C07D519/00
CPC分类号: A61K31/5386 , A61K31/437 , A61K31/4985 , A61K31/5383 , A61K31/551 , A61K31/553 , A61P35/00 , C07D471/06 , C07D487/06 , C07D498/06 , C07D498/22 , C07D519/00
摘要: The present invention provides compounds of Formula (I) or (II), pharmaceutical compositions thereof, and methods of using compounds of Formula (I) or (II) to prevent and/or treat immune-related disorders.
-
公开(公告)号:US20220227733A1
公开(公告)日:2022-07-21
申请号:US17281251
申请日:2020-02-20
发明人: Pan LI , Beidi XU , Qiaodong WEN , Enguang FENG , Ji WANG , Yang LU , Yu ZHOU , Zhiyong YU , Zhiying HUANG
IPC分类号: C07D401/14 , C07D405/14 , C07D403/06 , C07D403/12 , C07D401/12 , C07D471/04 , C07D471/10
摘要: Provided is a compound represented by formula (I) and a pharmaceutical composition thereof, as well as a method for using a compound represented by formula (I) to prevent and/or treat immune-related disorders.
-
公开(公告)号:US20240287093A1
公开(公告)日:2024-08-29
申请号:US17268613
申请日:2019-08-21
发明人: Yufeng CHEN , Kaixuan CHEN , Pan LI , Canfeng LIU , Ji WANG , Qingchong QIU , Yang LU
IPC分类号: C07D498/06 , A61K31/4985 , A61K31/5383 , A61K31/5517 , A61K31/553 , A61K45/06 , C07D487/06
CPC分类号: C07D498/06 , A61K31/4985 , A61K31/5383 , A61K31/5517 , A61K31/553 , A61K45/06 , C07D487/06
摘要: The present disclosure provides compounds of Formula (I), pharmaceutical compositions thereof, and methods of using compounds of Formula (I) to prevent and/or treat immune-related disorders.
-
-
-